Form 4: Intellia Therapeutics EVP, Chief Medical Officer David Lebwohl Reports Stock Transaction
SEC Form 4 Filing
David Lebwohl, EVP and Chief Medical Officer of Intellia Therapeutics, reports the vesting of restricted stock units and subsequent conversion to common stock.
Summary
- On January 1, 2025, David Lebwohl, EVP and Chief Medical Officer of Intellia Therapeutics, exercised restricted stock units (RSUs) which converted into 3,189 shares of common stock.
- Following the transaction, Lebwohl directly owns 97,223 shares of Intellia Therapeutics common stock.
- The reported transaction also includes shares acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 30, 2024 and December 31, 2024.
- Lebwohl also has a power of attorney agreement in place with James Basta and Edward Dulac to handle SEC filings.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by an executive, with no particularly positive or negative implications.
Industry Context
Form 4 filings are standard disclosures for company insiders, providing transparency into their transactions in the company's stock. This filing indicates routine vesting of previously granted equity.
Stakeholder Impact
- The transaction has a minor dilutive effect on existing shareholders due to the issuance of new shares.
Key Dates
| Date | Description |
|---|---|
| March 3, 2021 | Reporting person was granted 12,750 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. |
| November 5, 2024 | Date of execution for the Limited Power of Attorney. |
| June 30, 2024 | Reporting person acquired 405 shares under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan. |
| December 31, 2024 | Reporting person acquired 556 shares under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan. |
| January 1, 2025 | Date of transaction: conversion of restricted stock units into common stock. |
| January 3, 2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.